HEALTH● ELEVATEDJul 14 · Jul 14, 2026, 10:31 PM
WHO launches first trial of antiviral to prevent Bundibugyo strain of Ebola
France 24 [en]
The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of Ebola in the Democratic Republic of Congo, as the outbreak continues to outpace response efforts and spread beyond known chains of transmission.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH40m agoZamfara moves against Ebola virus threat, steps up surveillance, screens travellers at Gusau airportPremium TimesHEALTH1h agoEuropean disease control center sends experts to Nigeria while Ebola cases surpass 10,000 in CongoEuroNews [en]HEALTH1h agoAfrica Ebola outbreak passes 10,000 cases, mostly in DR CongoVanguard NigeriaHEALTH1h agoAfrica Ebola outbreak passes 10,000 cases, mostly in DR CongoLe Monde [en]